| Dr Craig Grinnell Hinman, MD | |
|
625 7th Ave E, Kalispell, MT 59901-5050 | |
| (509) 590-6827 | |
| Not Available |
| Full Name | Dr Craig Grinnell Hinman |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 625 7th Ave E, Kalispell, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598867061 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 99-223 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Craig Grinnell Hinman, MD 625 7th Ave E, Kalispell, MT 59901-5050 Ph: (509) 590-6827 | Dr Craig Grinnell Hinman, MD 625 7th Ave E, Kalispell, MT 59901-5050 Ph: (509) 590-6827 |
News Archive
Research by Johns Hopkins sensory biologists studying fruit flies, has revealed a critical step in fly vision. Humans with problems in this same step suffer retinal dystrophies, which manifest as visual defects ranging from mild visual impairments to complete blindness.
Prior Scientific, a leading developer of microscope accessories, has introduced a range of high performance stages, focus motors and automation software for the new Nikon Eclipse Ts2R - an intermediate-sized inverted research microscope designed for a wide variety of applications.
Locus Pharmaceuticals announced today that it has entered into a discovery research collaboration with Novartis. Locus will collaborate with Novartis to discover novel chemotypes on targets of interest to Novartis' select therapeutic areas.
An essential aspect of oral surgery is controlling the patient's pain following a procedure. The goal is to relieve pain and promote a rapid recovery, without opioid side effects. An initial study shows that Dyloject, a new intravenous form of the drug diclofenac, has promise for achieving these goals.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the investigational drug ILUVIEN® for the treatment of Diabetic Macular Edema (DME), today announced that Alimera Sciences, Inc, pSivida's collaborative partner, received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ILUVIEN. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form.
› Verified 4 days ago
Dr. Jerrod Tyler Heermans, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way Ste 2300, Kalispell, MT 59901 Phone: 406-890-7432 Fax: 406-890-7402 | |
Sarabeth Lee Martin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way Ste 2300, Kalispell, MT 59901 Phone: 406-890-7432 | |
Dr. Gregory Thomas Adams, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way, 2300, Kalispell, MT 59901 Phone: 406-752-8456 Fax: 406-755-1088 | |
Amy K Mckerrow, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way, Suite 2300, Kalispell, MT 59901 Phone: 406-752-8456 Fax: 406-752-1443 | |
John D Andenoro, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way Ste 2300, Kalispell, MT 59901 Phone: 406-752-8456 Fax: 406-752-1443 | |
Michael J Berson, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 169 Sunset Trl, Kalispell, MT 59901 Phone: 406-257-6888 |